New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 23, 2014
06:02 EDTLLYEli Lilly announces EC approval of Jardiance tablets for use in adults
The European Commission granted marketing authorization for Jardiance tablets, a sodium glucose co-transporter 2 inhibitor, for the treatment of type 2 diabetes mellitus to improve glycemic control in adults in Europe, Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly announced. The European Commission approved Jardiance 10 and 25 mg once daily tablets for use when diet and exercise alone do not provide adequate glycemic control. Jardiance may be used alone when metformin is not considered appropriate due to intolerance, or alongside other glucose-lowering medicines including insulin, when glucose control is inadequate.
News For LLY From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
September 4, 2015
09:20 EDTLLYARIAD drawing interest from companies besides Baxalta, dealReporter says
Subscribe for More Information
August 27, 2015
10:32 EDTLLYFDA approvals Synjardy tablets for adults with Type 2 diabetes
Subscribe for More Information
05:20 EDTLLYEli Lilly, Adocia initiate new Phase 1b study of BioChaperone Lispro
Subscribe for More Information
August 25, 2015
17:11 EDTLLYU.S. District Court rules in Eli Lilly's favor on Alimta vitamin regimen patent
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use